Addition of bevacizumab enhances antitumor activity of erlotinib against non-small cell lung cancer xenografts depending on VEGF expression
暂无分享,去创建一个
Y. Nakanishi | K. Takayama | I. Okamoto | I. Ieiri | T. Harada | Shuo Wang | Heyan Li | E. Iwama | Y. Shiraishi | Keisuke Gotanda | K. Furuyama